Hologic, Inc.
LSE: 0J5Q.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Paul Malenchini
- Employees
- 7,063
- Headquarters
- Marlborough, United States
- IPO year
- 2018
- Market cap
- $16.9B
- Website
- https://www.hologic.com
Loading 0J5Q…
Loading profile data…Frequently asked questions about 0J5Q
What does Hologic, Inc. (0J5Q.L) do?
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
Where does 0J5Q.L trade?
Hologic, Inc. (0J5Q.L) trades on the London Stock Exchange.
What sector is 0J5Q.L in?
Hologic, Inc. (0J5Q.L) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Hologic, Inc.?
Paul Malenchini is the chief executive officer of Hologic, Inc. (0J5Q.L).
Where is Hologic, Inc. headquartered?
Hologic, Inc. is headquartered in United States.
Does 0J5Q.L pay a dividend?
Hologic, Inc. (0J5Q.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0J5Q.L go public?
Hologic, Inc. (0J5Q.L) completed its initial public offering in 2018.